Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Gap Down - Here's Why

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $28.46, but opened at $27.30. Fresenius Medical Care AG & Co. KGaA shares last traded at $27.39, with a volume of 42,387 shares trading hands.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Truist Financial raised their price target on shares of Fresenius Medical Care AG & Co. KGaA from $25.00 to $30.00 and gave the company a "hold" rating in a report on Monday, May 12th. Morgan Stanley reaffirmed an "underweight" rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Thursday, May 15th. Finally, Wall Street Zen began coverage on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, May 20th. They issued a "strong-buy" rating for the company. One investment analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $27.80.

Fresenius Medical Care AG & Co. KGaA Stock Performance

The stock's 50 day moving average is $27.13 and its two-hundred day moving average is $24.86. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.08 and a current ratio of 1.46.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. The company had revenue of $5.54 billion for the quarter, compared to the consensus estimate of $4.71 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.18% and a return on equity of 6.25%. Analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 1.51 EPS for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The company also recently declared an annual dividend, which was paid on Friday, June 6th. Stockholders of record on Friday, May 23rd were given a $0.7871 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a dividend yield of 1.9%. This is a boost from Fresenius Medical Care AG & Co. KGaA's previous annual dividend of $0.44. Fresenius Medical Care AG & Co. KGaA's dividend payout ratio (DPR) is currently 50.89%.

Hedge Funds Weigh In On Fresenius Medical Care AG & Co. KGaA

Several hedge funds have recently bought and sold shares of the stock. Millennium Management LLC boosted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 50.0% in the 1st quarter. Millennium Management LLC now owns 1,083,602 shares of the company's stock valued at $26,982,000 after purchasing an additional 361,364 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 14.2% during the first quarter. AQR Capital Management LLC now owns 14,297 shares of the company's stock worth $356,000 after buying an additional 1,777 shares during the period. Advisors Asset Management Inc. grew its position in Fresenius Medical Care AG & Co. KGaA by 243.3% in the 1st quarter. Advisors Asset Management Inc. now owns 7,817 shares of the company's stock valued at $195,000 after buying an additional 5,540 shares in the last quarter. Vident Advisory LLC boosted its stake in Fresenius Medical Care AG & Co. KGaA by 131.8% during the 1st quarter. Vident Advisory LLC now owns 54,274 shares of the company's stock valued at $1,351,000 after purchasing an additional 30,864 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 5.0% during the 1st quarter. Northern Trust Corp now owns 380,251 shares of the company's stock valued at $9,468,000 after purchasing an additional 18,061 shares in the last quarter. Hedge funds and other institutional investors own 8.37% of the company's stock.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.